TY - JOUR
T1 - Iatrogenic cerebral amyloid angiopathy in older adults
AU - Panteleienko, Larysa
AU - Mallon, Dermot
AU - Oliver, Rupert
AU - Toosy, Ahmed
AU - Hoshino, Yuki
AU - Murakami, Aya
AU - Kaushik, Kanishk
AU - Wermer, Marieke J.H.
AU - Hara, Hideo
AU - Yakushiji, Yusuke
AU - Banerjee, Gargi
AU - Werring, David J.
N1 - Publisher Copyright:
© 2024 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
PY - 2024/6
Y1 - 2024/6
N2 - Background and purpose: An increasing number of cases of iatrogenic cerebral amyloid angiopathy (CAA) have now been reported worldwide. Proposed diagnostic criteria require a history of medical intervention with potential for amyloid-β transmission, for example those using cadaveric dura mater or requiring instrumentation of the brain or spinal cord. Clinical presentation occurs after an appropriate latency (usually three or four decades); to date, most patients with iatrogenic CAA have had ‘early-onset’ disease (compared to sporadic, age-related, CAA), as a consequence of childhood procedures. Results: We describe five cases of possible iatrogenic CAA in adults presenting in later life (aged 65 years and older); all had prior neurosurgical interventions and presented after a latency suggestive of iatrogenic disease (range 30–39 years). Use of cadaveric dura mater was confirmed in one case, and highly likely in the remainder. Conclusion: The presentation of iatrogenic CAA in older adults widens the known potential spectrum of this disease and highlights the difficulties of making the diagnosis in this age group, and particularly in differentiating iatrogenic from sporadic CAA. Increased vigilance for cases presenting at an older age is essential for furthering our understanding of the clinical phenotype and broader implications of iatrogenic CAA.
AB - Background and purpose: An increasing number of cases of iatrogenic cerebral amyloid angiopathy (CAA) have now been reported worldwide. Proposed diagnostic criteria require a history of medical intervention with potential for amyloid-β transmission, for example those using cadaveric dura mater or requiring instrumentation of the brain or spinal cord. Clinical presentation occurs after an appropriate latency (usually three or four decades); to date, most patients with iatrogenic CAA have had ‘early-onset’ disease (compared to sporadic, age-related, CAA), as a consequence of childhood procedures. Results: We describe five cases of possible iatrogenic CAA in adults presenting in later life (aged 65 years and older); all had prior neurosurgical interventions and presented after a latency suggestive of iatrogenic disease (range 30–39 years). Use of cadaveric dura mater was confirmed in one case, and highly likely in the remainder. Conclusion: The presentation of iatrogenic CAA in older adults widens the known potential spectrum of this disease and highlights the difficulties of making the diagnosis in this age group, and particularly in differentiating iatrogenic from sporadic CAA. Increased vigilance for cases presenting at an older age is essential for furthering our understanding of the clinical phenotype and broader implications of iatrogenic CAA.
KW - amyloid-β
KW - cadaveric dura mater
KW - iatrogenic cerebral amyloid angiopathy
KW - neurosurgery
KW - prion
UR - http://www.scopus.com/inward/record.url?scp=85188708379&partnerID=8YFLogxK
U2 - 10.1111/ene.16278
DO - 10.1111/ene.16278
M3 - Article
C2 - 38511868
AN - SCOPUS:85188708379
SN - 1351-5101
VL - 31
JO - European Journal of Neurology
JF - European Journal of Neurology
IS - 6
M1 - e16278
ER -